Company / Total Assets
Bio-Rad Laboratories Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$10.6B
FY2025
5-year range
$9.4B / $17.8B
FY2021-FY2025
Trend
+12.9%
vs FY2024
Sector context
#38 of 161
Health Care
What the data says
Bio-Rad Laboratories's total assets of $10.6B is higher than 76% of companies in the Health Care sector (FY2025). Total Assets returned to growth in FY2025 after 3 years of decline, reaching $10.6B.
Based on SEC 10-K filings.
$10.6B in FY2025 with a 5-year CAGR of -4.0%. Top quartile in the Health Care sector.
Declined from $12.3B to $10.6B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -7.8%
- 5-Year CAGR
- -4.0%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 161This company $10.6B Sector average $14.8B
▼
-28.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -4.0%, indicating a declining trend.
- In FY2025, total assets increased 12.9% year-over-year.
- Ranks #38 out of 161 companies in the Health Care sector.
- Peak total assets was recorded in FY2021.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.6B | +12.9% |
| FY2024 | $9.4B | -23.9% |
| FY2023 | $12.3B | -8.9% |
| FY2022 | $13.5B | -24.1% |
| FY2021 | $17.8B | +37.2% |
| FY2020 | $13.0B | +62.0% |
| FY2019 | $8.0B | +42.7% |
| FY2018 | $5.6B | +31.3% |
| FY2017 | $4.3B | +11.0% |
| FY2016 | $3.9B | +3.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026